Weight Loss
Conditions
Brief summary
The purpose of this study is to conduct a pilot randomized controlled trial, to determine whether providing financial incentives for meeting daily step goals (a) increases the daily step counts of participants, (b) increases compliance with the overall program (including diet recommendations), and (c) increases weight loss.
Interventions
Participants' daily activity was incentivized. Reaching a predetermined/individualized step goal each day resulted in 1.00 per day.
Standard payment of 70.00 at the beginning of the study. Participants' daily activity was not incentivized.
Sponsors
Study design
Eligibility
Inclusion criteria
* required to be able to read. * required to have access to a computer. * required to have a body mass index between 27 and 45 kg.m-2. * required to take fewer than 7,000 steps per day at baseline (as determined by a pedometer, averaged across 4-7 days).
Exclusion criteria
* Individuals who report having an injury or physical limitation that renders them unable to walk ¼ mile without difficulty. * Uncontrolled cardiovascular or metabolic condition determined by health history questionnaire.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Daily Step Count | Change from week 1 to week 12 | Change in steps/day from week 1 to week 12. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Program Compliance | Change from week 1 to week 12 | Compliance with the physical activity prescription, means meeting or exceeding the step goal for that day. Participants' compliance was assessed by totaling the number of days they met their step goal and dividing it by the total number of days of the intervention. Thus, providing investigators the percentage of days that each participant complied with their physical activity prescription. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Weight Loss | Change from week 1 to week 12. There will also be measures taken 3 months following week 12 | Change in weight, waist circumference, and hip circumference from week 1 to week 12. There will also be measures taken 3 months following week 12. This will be defined as the follow-up data. |
Countries
United States